OnCore Login
network member

Tennessee

About Network Member

Currently Enrolling

HCRN-GU23-651

A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
Brian Rini
Cancer areas:Kidney
Vanderbilt-Ingram Cancer Center
Learn More
See clinicaltrials.gov
Enrollment Closed

HCRN-GU18-343

A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)
Deepak Kilari
Cancer areas:Bladder
Froedtert & the Medical College of Wisconsin
John Theurer Cancer Center at Hackensack Meridian Health
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
University of Rochester Medical Center - Wilmot Cancer Institute
Vanderbilt-Ingram Cancer Center
Virginia Commonwealth University
Learn More
See clinicaltrials.gov
Enrollment Closed

TBCRC047

Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study
Hope Rugo
Cancer areas:Breast
Dana-Farber Cancer Institute
Duke Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
University of Alabama at Birmingham Comprehensive Cancer Center
University of North Carolina Lineberger Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Learn More
See clinicaltrials.gov